Kurt Christensen, PhD, is an Assistant Professor at the Harvard Pilgrim Health Care Institute and Harvard Medical School whose research focuses on the medical, behavioral, and economic impact of integrating genomic tools into clinical and research settings. He has been an investigator on numerous high-profile NIH-funded studies of genomic information disclosure. His published work has not only provided some of the earliest insight about the implications of population genomic screening for health systems, providers, and patients, but also about the best methods for examining these issues. Dr. Christensen is currently supported by an NIH Career Development award focused on the cost-effectiveness of providing genetic screening to healthy adults. He is also a co-investigator on the PreEMPT Model, an NIH-funded effort to develop a simulation model to examine the economic impact of screening newborns for genetic risk factors, and leads a collaboration with the Sanford Imagenetics Program to examine the impact of providing genetic screening in primary care settings.